Human T Regulatory Cells Can Use the Perforin Pathway to Cause Autologous Target Cell Death
Overview
Authors
Affiliations
Cytotoxic T lymphocytes and natural killer cells use the perforin/granzyme pathway to kill virally infected cells and tumor cells. Mutations in genes important for this pathway are associated with several human diseases. CD4(+) T regulatory (Treg) cells have emerged as important in the control of immunopathological processes. We have previously shown that human adaptive Treg cells preferentially express granzyme B and can kill allogeneic target cells in a perforin-dependent manner. Here, we demonstrate that activated human CD4(+)CD25(+) natural Treg cells express granzyme A but very little granzyme B. Furthermore, both Treg subtypes display perforin-dependent cytotoxicity against autologous target cells, including activated CD4(+) and CD8(+) T cells, CD14(+) monocytes, and both immature and mature dendritic cells. This cytotoxicity is dependent on CD18 adhesive interactions but is independent of Fas/FasL. Our findings suggest that the perforin/granzyme pathway is one of the mechanisms that Treg cells can use to control immune responses.
T Cell Resistance: On the Mechanisms of T Cell Non-activation.
Beckers D, Jainarayanan A, Dustin M, Capera J Immune Netw. 2025; 24(6):e42.
PMID: 39801736 PMC: 11711127. DOI: 10.4110/in.2024.24.e42.
Han J, Park S Clin Transplant Res. 2024; 38(4):257-272.
PMID: 39696994 PMC: 11732766. DOI: 10.4285/ctr.24.0059.
Cochrane R, Robino R, Granger B, Allen E, Vaena S, Romeo M Mol Ther Methods Clin Dev. 2024; 32(4):101385.
PMID: 39687729 PMC: 11647616. DOI: 10.1016/j.omtm.2024.101385.
CD137-expressing regulatory T cells in cancer and autoimmune diseases.
Lee K, Mei Y, Liu H, Schwarz H Mol Ther. 2024; 33(1):51-70.
PMID: 39668561 PMC: 11764688. DOI: 10.1016/j.ymthe.2024.12.010.
The 'T paradox' in inflammatory arthritis.
Schnell J, Briviesca R, Kim T, Charbonnier L, Henderson L, van Wijk F Nat Rev Rheumatol. 2024; 21(1):9-21.
PMID: 39653758 DOI: 10.1038/s41584-024-01190-w.